Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 27 Aug 2026 for Indivior Pharmaceuticals, Inc., €46k.
Filing timeline
BuySaleWoodrow D. Anderson
Insider track record
Disclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Woodrow D. Anderson: trading record in brief
Woodrow D. Anderson is a declared insider of Indivior Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). We count 7 filings; the first trade dates from 10 February 2026 and the latest from 27 August 2026.
Purchases make up the whole of the open-market record (2 purchases, €93k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 3 share grants and 2 option exercises.
Most recently, on 27 August 2026, the filings show an open-market purchase worth €46k in Indivior Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Woodrow D. Anderson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
1,500 shares@ US$35.69Common StockSEC:0002014440-26-000012:0
Canonical exit: 25 Nov 2026 (T+90)
1,500 shares@ US$36.280.0013% mcap100.0% of flowCommon StockSEC:0002014440-26-000010:0
Canonical exit: 3 Nov 2026 (T+90)
18,364 sharesCommon StockSEC:0002014440-26-000007:0
6,903 shares0Common StockSEC:0002014440-26-000005:0
4 of 4 declarations
